Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26F1Q66
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $88,311
Award facts
- Contract value 100% obligated
- $88,311.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $88.3K to AmerisourceBergen Drug Corp for the supply of Dupixent 300 mg/2 mL pen injectors. The contract, issued on December 19, 2025, with an ultimate completion date of December 22, 2025, utilizes firm fixed-price pricing and carries no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.9M through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, and specialized healthcare commodities. The company's extensive portfolio of DLA contracts demonstrates its capability to fulfill diverse pharmaceutical needs across multiple therapeutic domains for military and veteran healthcare systems, including the Defense Health Agency and U.S. Coast Guard. Dupixent is a prescription biologic medication used to treat conditions such as atopic dermatitis and asthma, representing the type of specialty pharmaceutical product that AmerisourceBergen routinely supplies through its federal contract vehicles.
Quick answers
Who was awarded contract SPE2DR26F1Q66?
SPE2DR26F1Q66 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 19, 2025.
How much is contract SPE2DR26F1Q66 worth?
The government has obligated $88,311 on SPE2DR26F1Q66.
Is contract SPE2DR26F1Q66 an order under another contract?
Yes. SPE2DR26F1Q66 is a delivery order under SPE2DR25D2205, an indefinite delivery contract.
Was contract SPE2DR26F1Q66 competed?
The extent of competition for SPE2DR26F1Q66 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award